Studies have found hepcidin decreased in AD affected neurons (Raha et al., 2013), while exogenous hepcidin supplement normalized the levels of iron transport proteins, thereby reducing iron level in the brain (Du et al., 2015). This evidence concerns the gene HAMP and Alzheimer disease.